Logo image of ASLE

AERSALE CORP (ASLE) Stock Fundamental Analysis

NASDAQ:ASLE - Nasdaq - US00810F1066 - Common Stock - Currency: USD

6.57  +0.21 (+3.3%)

Fundamental Rating

4

ASLE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Aerospace & Defense industry. ASLE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASLE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ASLE had positive earnings in the past year.
In the past year ASLE had a positive cash flow from operations.
Of the past 5 years ASLE 4 years were profitable.
In multiple years ASLE reported negative operating cash flow during the last 5 years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

ASLE has a Return On Assets (0.97%) which is comparable to the rest of the industry.
ASLE has a Return On Equity (1.28%) which is in line with its industry peers.
ASLE's Return On Invested Capital of 1.37% is on the low side compared to the rest of the industry. ASLE is outperformed by 66.15% of its industry peers.
Industry RankSector Rank
ROA 0.97%
ROE 1.28%
ROIC 1.37%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

ASLE has a Profit Margin (1.70%) which is comparable to the rest of the industry.
ASLE's Profit Margin has declined in the last couple of years.
ASLE has a worse Operating Margin (2.82%) than 64.62% of its industry peers.
ASLE's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 30.12%, ASLE is doing good in the industry, outperforming 67.69% of the companies in the same industry.
ASLE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.82%
PM (TTM) 1.7%
GM 30.12%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASLE is destroying value.
The number of shares outstanding for ASLE has been increased compared to 1 year ago.
Compared to 5 years ago, ASLE has more shares outstanding
The debt/assets ratio for ASLE has remained at the same level compared to a year ago.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

ASLE has an Altman-Z score of 2.72. This is not the best score and indicates that ASLE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.72, ASLE is in line with its industry, outperforming 49.23% of the companies in the same industry.
ASLE has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
ASLE's Debt to Equity ratio of 0.09 is amongst the best of the industry. ASLE outperforms 81.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACC0.13
WACC10.36%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 3.79 indicates that ASLE has no problem at all paying its short term obligations.
ASLE has a better Current ratio (3.79) than 81.54% of its industry peers.
ASLE has a Quick Ratio of 3.79. This is a bad value and indicates that ASLE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.79, ASLE is not doing good in the industry: 81.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 0.79
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

ASLE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 171.43%, which is quite impressive.
The Earnings Per Share has been growing by 22.36% on average over the past years. This is a very strong growth
ASLE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.16%.
The Revenue has been growing slightly by 0.45% on average over the past years.
EPS 1Y (TTM)171.43%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%550%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%0.34%

3.2 Future

Based on estimates for the next years, ASLE will show a very strong growth in Earnings Per Share. The EPS will grow by 84.63% on average per year.
The Revenue is expected to grow by 15.82% on average over the next years. This is quite good.
EPS Next Y160.37%
EPS Next 2Y84.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.29%
Revenue Next 2Y15.82%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.58 indicates a quite expensive valuation of ASLE.
61.54% of the companies in the same industry are more expensive than ASLE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ASLE to the average of the S&P500 Index (28.33), we can say ASLE is valued slightly more expensively.
With a Price/Forward Earnings ratio of 13.28, ASLE is valued correctly.
Based on the Price/Forward Earnings ratio, ASLE is valued cheaper than 95.38% of the companies in the same industry.
ASLE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.37, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.58
Fwd PE 13.28
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ASLE is valued a bit cheaper than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.55
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ASLE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ASLE's earnings are expected to grow with 84.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)1.55
EPS Next 2Y84.63%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AERSALE CORP

NASDAQ:ASLE (4/23/2025, 9:47:00 AM)

6.57

+0.21 (+3.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners45.25%
Inst Owner Change-0.88%
Ins Owners7.3%
Ins Owner Change-493.86%
Market Cap350.05M
Analysts80
Price Target8.16 (24.2%)
Short Float %6.36%
Short Ratio6.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.21%
Min EPS beat(2)-26.47%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)-5.92%
Min EPS beat(4)-149.02%
Max EPS beat(4)153.75%
EPS beat(8)1
Avg EPS beat(8)-46.98%
EPS beat(12)4
Avg EPS beat(12)-2.02%
EPS beat(16)8
Avg EPS beat(16)41.6%
Revenue beat(2)1
Avg Revenue beat(2)-5.73%
Min Revenue beat(2)-12.68%
Max Revenue beat(2)1.22%
Revenue beat(4)2
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-13.25%
Max Revenue beat(4)3.91%
Revenue beat(8)2
Avg Revenue beat(8)-14.37%
Revenue beat(12)4
Avg Revenue beat(12)-9.24%
Revenue beat(16)6
Avg Revenue beat(16)-6.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.73%
EPS NY rev (1m)28.76%
EPS NY rev (3m)5.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.11%
Revenue NY rev (1m)-4.66%
Revenue NY rev (3m)-2.8%
Valuation
Industry RankSector Rank
PE 34.58
Fwd PE 13.28
P/S 1.01
P/FCF N/A
P/OCF 31.3
P/B 0.77
P/tB 0.84
EV/EBITDA 14.55
EPS(TTM)0.19
EY2.89%
EPS(NY)0.49
Fwd EY7.53%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.21
OCFY3.19%
SpS6.48
BVpS8.55
TBVpS7.79
PEG (NY)0.22
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA 0.97%
ROE 1.28%
ROCE 1.84%
ROIC 1.37%
ROICexc 1.39%
ROICexgc 1.5%
OM 2.82%
PM (TTM) 1.7%
GM 30.12%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-51.13%
ROICexcg growth 5YN/A
ROICexc growth 3Y-49.58%
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA 1.57
Cap/Depr 87.56%
Cap/Sales 4.07%
Interest Coverage 1.73
Cash Conversion 43.36%
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 0.79
Altman-Z 2.72
F-Score5
WACC10.36%
ROIC/WACC0.13
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)171.43%
EPS 3Y-40.01%
EPS 5Y22.36%
EPS Q2Q%550%
EPS Next Y160.37%
EPS Next 2Y84.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.16%
Revenue growth 3Y0.45%
Revenue growth 5YN/A
Sales Q2Q%0.34%
Revenue Next Year13.29%
Revenue Next 2Y15.82%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y190.39%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year405.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.42%
OCF growth 3Y-47.9%
OCF growth 5YN/A